Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Health groups...

    Health groups disappointed over SC's stand on vaccines case

    Written by Ruby Khatun Khatun Published On 2018-02-24T10:15:19+05:30  |  Updated On 24 Feb 2018 10:15 AM IST
    Health groups disappointed over SCs stand on vaccines case

    New Delhi: Health groups expressed disappointment over the Supreme Court refusing to recall its earlier order in which it had disposed of a plea seeking an enquiry into alleged negligence by the government in running public sector laboratories involved in making vaccines.


    The groups are now considering filing a fresh petition, as the court also said in case there is any deficiency or neglect on the part of the Government... the petitioner shall be free to seek appropriate redress in appropriate proceedings at the appropriate stage.


    Dr Mira Shiva of AIDAN, a petitioner in the case, claimed the court relied only on the government's claims regarding revival and modernization of suspended public sector laboratories and did not take into account the last rejoinder of the petitioners that highlighted the increasing diversion of purchase orders to the private sector at ever-increasing prices.


    The PIL was filed by former Union health secretary SP Shukla and representatives of the All India Drug Action Network (AIDAN), Low Cost Standard Therapeutics (LOCOST), Medico Friend Circle (MFC), and Society for Scientific Values (SSV).


    Shukla, who is the main petitioner, said they have won half the battle with the revival of the suspended PSUs and their modernization for compliance with good manufacturing practices (GMP), under the pressure of the case.


    "But their production is yet to be restored to pre-suspension levels, the responsibility for mala fide suspension was not fixed, and even the recommendations of the Javid Chowdhury Committee have not been fully implemented," he said.


    According to S Srinivasan of LOCOST, the government has not been buying vaccines from the public sector even after their revival.


    "Government data show that purchase orders to PSUs are declining and those to private companies are growing despite increasing prices. We highlighted all these issues in our last affidavit on 2016 to show that the Government of India is misleading the Supreme Court, but it was not taken into account," Srinivasan said.


    "We neither have a rational vaccine policy nor the rational use of vaccines.


    For example, selective immunization has disappeared from government policy. New vaccines and their combinations of doubtful efficacy and safety are being introduced in the universal immunization programme.


    "By shifting its procurement towards irrational cocktail vaccines made only by the private sector, the government is systematically reducing PSUs into component suppliers to the private sector," Dr Shiva alleged.

    AIDANAll India Drug Action NetworkDr Mira ShivaGMPgood manufacturing practicesHealth groupsLOCOSTLow Cost Standard TherapeuticsMedico Friend CirclepetitionrecallSociety for Scientific ValuesSupreme Courtvaccines case
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok